High-intensity statins are associated with improved clinical activity of PD-1 inhibitors in malignant pleural mesothelioma and advanced non-small cell lung cancer patients
Luca Cantini, Federica Pecci, Daan P. Hurkmans, Robert A. Belderbos, Andrea Lanese, Cecilia Copparoni, Sophie Aerts, Robin Cornelissen, Daphne W. Dumoulin, Ilaria Fiordoliva, Silvia Rinaldi, Joachim G.J.V. Aerts, Rossana Berardi
Topics & Concepts
MedicineInternal medicineLung cancerHazard ratioCohortChemotherapyGastroenterologyStatinOncologyCancerGemcitabineProgression-free survivalAdjuvantSurgeryConfidence intervalCancer, Lipids, and MetabolismCancer Research and TreatmentsCancer Immunotherapy and Biomarkers